Related Experiment Videos
Helium-oxygen mixture for nonintubated acute asthma patients
G Rodrigo1, C Rodrigo, C Pollack
1Departamento de Emergencia, Hospital Central de las FF.AA., Av. 8 de Octubre 3020', Montevideo, Uruguay, 11600. gurodrig@adinet.com.uy
The Cochrane Database of Systematic Reviews
|May 2, 2001
Summary
Helium-oxygen (heliox) therapy does not significantly improve outcomes for patients with acute severe asthma. Current evidence suggests heliox has no role in the initial emergency treatment of asthma exacerbations.
Area of Science:
- Respiratory Medicine
- Emergency Medicine
- Critical Care
Background:
- Helium and oxygen mixtures (heliox) have been explored for respiratory conditions for decades.
- The efficacy of heliox in acute severe asthma remains debated despite extensive research.
- Its role in managing acute respiratory emergencies like asthma is not clearly defined.
Purpose of the Study:
- To evaluate the impact of heliox on acute asthma management.
- Assessed pulmonary function tests and clinical outcomes in asthma patients.
- Determined the effectiveness of heliox as an adjunct to standard asthma care.
Main Methods:
- Systematic review of randomized controlled trials (RCTs) from major databases and expert consultation.
- Inclusion criteria: RCTs in adults and children with acute asthma comparing heliox to control.
- Data analysis involved random-effects modeling with sensitivity analyses for subgroups.
Main Results:
- Four RCTs with 288 patients were analyzed; two were low quality.
- No significant differences in pulmonary function tests were observed with heliox. (WMD = -1.61; 95% CI: -6.64 to 3.41)
- Subgroup analyses (age, quality, heliox dose) showed no significant benefits.
Conclusions:
- Current evidence does not support heliox administration for moderate to severe acute asthma in emergency settings.
- Heliox is not recommended for the initial treatment phase of acute asthma.
- Further research may be needed, but current findings indicate limited utility.